Open multicentre, phase IV study to evaluate efficacy and safety of pegylated interferon alpha-2a (40 KD) plus ribavirin for chronic hepatitis C with normal transaminases in human immunodeficiency virus-infected patients
2013 ◽
Vol 37
(4)
◽
pp. 491-491
◽
2009 ◽
Vol 17
(6)
◽
pp. 410-418
◽
2009 ◽
Vol 3
(1)
◽
pp. 17-19
◽